Phillip Advincula has a background in rare disease management, clinical trials, and commercial launches in the pharmaceutical industry. Previous roles include working with organizations such as Rhythm Pharmaceuticals, Apellis Pharmaceuticals, Akcea Therapeutics, Shire, Slate Pharmaceuticals, ISTA Pharmaceuticals, Novartis, and University of Illinois at Chicago. Phillip has experience in areas such as rare genetic diseases, hematology, ophthalmology, neurology, and urology. Phillip holds a Bachelor of Science degree in Biochemistry from the University of Illinois Chicago.
This person is not in any offices